Nontraditional Risk Factors for Peripheral Artery Disease: Setting the Scene

Atherothrombotic occlusion and narrowing of the arteries supplying blood to the legs, usually referred to as peripheral artery disease, affects 6% of adults and is associated with impaired quality of life and increased risk of major adverse events including death. Peripheral artery disease has been...

Full description

Saved in:
Bibliographic Details
Published inArteriosclerosis, thrombosis, and vascular biology Vol. 45; no. 9; pp. 1488 - 1492
Main Authors Allison, Matthew A., Powell, Janet T., Golledge, Jonathan
Format Journal Article
LanguageEnglish
Published Hagerstown, MD Lippincott Williams & Wilkins 01.09.2025
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Atherothrombotic occlusion and narrowing of the arteries supplying blood to the legs, usually referred to as peripheral artery disease, affects 6% of adults and is associated with impaired quality of life and increased risk of major adverse events including death. Peripheral artery disease has been relatively understudied and has not been subject to the same scrutiny and investigation that characterizes coronary artery disease. Importantly, there are subtle differences between peripheral and coronary artery disease with respect to traditional risk factors, and there may be marked differences in nontraditional risk factors. Here, we provide a brief description of the population burden, pathophysiology, and traditional risk factors for peripheral artery disease, which is intended as the introduction to a series of reviews focusing on nontraditional risk factors for this disorder. We highlight the planned reviews in the series and how these may act as an important impetus to address the unmet need of improving outcomes in people with peripheral artery disease.
Bibliography:ATVB in Focus: Nontraditional Risk Factors for Peripheral Arterial Disease: The Evidence and Underlying Mechanisms Series Editors: Matthew Allison, Jonathan Golledge, and Janet Powell For Sources of Funding and Disclosures, see page 1491. *M.A. Allison, J.T. Powell, and J. Golledge contributed equally. This article was sent to Luisa Iruela-Aripse, Handling Editor, for review by expert referees, editorial decision, and final disposition. Correspondence to: Matthew A. Allison, MD, MPH, Division of Preventive Medicine, Department of Family Medicine, University of California San Diego, 9500 Gilman Dr, La Jolla, CA 92093, Email mallison@health.ucsd.edu Jonathan Golledge, MB BChir, MA, MChir, Queensland Research Centre for Peripheral Vascular Disease and Department of Vascular and Endovascular Surgery, James Cook University and Townsville University Hospital, Townsville, Australia, Email jonathan.golledge@jcu.edu.au
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:1079-5642
1524-4636
1524-4636
DOI:10.1161/ATVBAHA.125.323193